Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,888 | Dovepress* | 8,371+ | 1,578 | 9,949 | |
PubMed Central* | 517 | 186 | 703 | ||
Totals | 8,888 | 1,764 | 10,652 | ||
*Since 10 April 2015 +Since July 2016 |
View citations on PubMed and Google Scholar